Accendra Health (FRA:6OM) Selling, General, & Admin. Expense: €891 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:6OM Accendra Health Inc FRA:6OM
53 GF Score
Price €1.04
GF Value €4.39
! 6 Warning Signs
View Full Analysis

What is Accendra Health Selling, General, & Admin. Expense?

Accendra Health FRA:6OM -15.45% 53 Selling, General, & Admin. Expense is €891 Mil as of Jun. 2026. GuruFocus rates FRA:6OM with a GF Score™ of 53/100 and a GF Value™ of €4.39. The stock has 6 warning signs investors should review.

Selling, general, & admin. expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. Accendra Health's selling, general, & admin. expense for the three months ended in Jun. 2026 was €211 Mil. Its selling, general, & admin. expense for the trailing twelve months (TTM) ended in Jun. 2026 was €891 Mil.


Accendra Health  (FRA:6OM) Selling, General, & Admin. Expense Explanation

An efficient operation keeps SGA costs low and thus has higher profit margin. The percentage of SGA relative to total revenue is an indication of how efficiently the company operates. Compare this percentage among the companies in the same industry is a good way of finding more efficient operations. A comparison of the SGA cost relative to the revenue with the historical value can also be an indication of how efficient the company has become.

Warren Buffett likes companies with consistent SGA as the percentage of gross profit.

Companies with no durable competitive advantage show wild variation in SG&A as % of Gross Profit.

If SGA is less than 30% of Gross Profit, it is fantastic. If SGA is nearing 100%, it is is in highly competitive industry.


Accendra Health Selling, General, & Admin. Expense Related Terms


Accendra Health Selling, General, & Admin. Expense Historical Data

* Premium members only.

The historical data trend for Accendra Health's Selling, General, & Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Accendra Health Selling, General, & Admin. Expense Chart

Accendra Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Selling, General, & Admin. Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 953.20 1,467.75 918.52 1,033.64 911.70

Accendra Health Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Selling, General, & Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 232.23 226.49 231.86 220.77 211.41

FRA:6OM vs FOCL, YI, COSM: Selling, General, & Admin. Expense Comparison

For the Medical Distribution subindustry, Accendra Health's Selling, General, & Admin. Expense, along with its competitors' market caps and Selling, General, & Admin. Expense data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Accendra Health Selling, General, & Admin. Expense vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Accendra Health's Selling, General, & Admin. Expense distribution charts can be found below:

* The bar in red indicates where Accendra Health's Selling, General, & Admin. Expense falls into.


FRA:6OM
53GF Score
Accendra Health Inc FRA:6OM
Selling, General, & Admin. Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Accendra Health Selling, General, & Admin. Expense Calculation

Selling, General, & Admin. Expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. For instance, personnel cost, advertising, rent, communication costs are all part of SGA.

Selling, General, & Admin. Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €891 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Selling, General, & Admin. Expense of €891 Mil mean?
Accendra Health (FRA:6OM) has a Selling, General, & Admin. Expense of €891 Mil as of Jun. 2026. Selling, general and admin expense is the total cost for direct, indirect, general and administrative activities. View historical data on Accendra Health and its competitors.
Is Accendra Health's Selling, General, & Admin. Expense too high?
Accendra Health's current Selling, General, & Admin. Expense is €891 Mil. Overall, Accendra Health has a GF Score™ of 53/100, reflecting its overall financial health beyond just this single metric.
How does Accendra Health's Selling, General, & Admin. Expense compare to FOCL and YI?
Accendra Health's Selling, General, & Admin. Expense of €891 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Selling, General, & Admin. Expense for a Medical Distribution company?
A good Selling, General, & Admin. Expense depends on the Medical Distribution industry context. However, Selling, General, & Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Selling, General, & Admin. Expense mean?
A high Selling, General, & Admin. Expense can signal that a stock is expensive relative to its fundamentals. Selling, general and admin expense is the total cost for direct, indirect, general and administrative activities. View historical data on Accendra Health and its competitors. Accendra Health's current Selling, General, & Admin. Expense is €891 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accendra Health stock overvalued right now?
Accendra Health (FRA:6OM) has a current Selling, General, & Admin. Expense of €891 Mil. The stock's GF Value™ is €4.39, compared to a current price of €1.04 — trading 76.3% below its estimated fair value. The current Selling, General, & Admin. Expense is €891 Mil. Accendra Health's overall GF Score™ is 53/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Selling, General, & Admin. Expense calculated?
Selling, General, & Admin. Expense is calculated from a company's financial statements. For Accendra Health (FRA:6OM), the current Selling, General, & Admin. Expense is €891 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Accendra Health (FRA:6OM) Overvalued in 2026?

Based on GuruFocus' analysis, Accendra Health stock appears to be undervalued. The current stock price of €1.04 is trading 76.3% below its estimated GF Value™ of €4.39.

Key valuation signals for FRA:6OM:

  • Selling, General, & Admin. Expense: €891 Mil
  • GF Value™: €4.39 vs. price of €1.04 (76.3% below fair value)
  • GF Score™: 53/100 with 6 warning signs

No single metric tells the full story. See the FRA:6OM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Accendra Health Business Description

Other Exchanges ACH:USA6OM:Germany
Address 10900 Nuckols Road, Suite 400, Glen Allen, VA, USA, 23060
Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.
53GF Score

Get the complete analysis for FRA:6OM

Selling, General, & Admin. Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.04
Price
€4.39
GF Value